Evaluation of vancomycin-associated nephrotoxicity before and after implementation of an intensive pharmacist monitoring program.
MedStar author(s):Citation: Unpublished 2017/12/03Department: PharmacyForm of publication: Poster PresentationYear: 2017Conference information: MedStar Washington Hospital Center: American Society of Health-System Pharmacists Midyear Meeting, Orlando, FL, All authors: El-gendi S, Leftridge ZFiscal year: FY2018/Local accession number: A2017_442Date added to catalog: 2018-08-01
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Poster Presentation | MedStar Authors Catalog | Poster | Available |
-
1
Extremely Low Prevalence of Takotsubo Cardiomyopathy and Transient Cardiac Dysfunction in Stroke Patients With T-wave Abnormalities.
-
2
Letter to the Editor in response to "Role of Subcutaneous Leadless Implantable Cardioverter Defibrillator in Young Patients".
-
3
Spontaneous Coronary Artery Dissection in a Liver Transplantation Candidate.
-
4
Pulmonary Artery Catheterization.
-
5
Minimally Invasive Aortic Valve Surgery.
-
6
Letter by Khalid et al Regarding Article, "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy".
-
7
Letter to the Editor in Response to "Cardiac Autonomic Neuropathy in Diabetes Mellitus".
-
8
Use and Application Of MAUDE In Patient Safety. [Review]
-
9
Takotsubo Cardiomyopathy.
-
10
Pericardial Calcification.
-
11
Pathophysiology of Takotsubo Syndrome.
-
12
Factors impacting prognosis among patients with tako-tsubo syndrome.
-
13
Takotsubo syndrome: The past, the present and the future.
-
14
Mortality in Takotsubo cardiomyopathy should also be accounted based on predisposing etiology.
-
15
Cardiovascular complications in COVID-19.
-
16
Racial and gender disparities among patients with Takotsubo syndrome.
-
17
Sex disparities and microvascular dysfunction.
-
18
Intravascular Ultrasound (IVUS). [Review]
-
19
Calcified Plaque. [Review]
-
20
Aortic Valve Endocarditis. [Review]
-
21
Myocardial fibrosis and arrhythmogenesis in elite athletes.
-
22
Takotsubo cardiomyopathy: prognostication is affected by the underlying trigger.
-
23
Aortic Valve Endocarditis Surgical Treatment. [Review]
-
24
Electrocardiographic changes in Takotsubo cardiomyopathy. [Review]
-
25
Expanding the Treatment of Calcified Lesions.
-
26
Editorial commentary: Out on a limb: The critical need for high-quality evidence in critical limb ischemia.
-
27
Intravascular Lithotripsy-Facilitated Carotid Interventions.
-
28
Letter by Khalid et al Regarding Article, "Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction: A Pilot Study Using the Impella CP".
-
29
Response by Khalid et al to Letter Regarding Article, "Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support".
-
30
Spontaneous dissections involving multiple coronary arteries and a vertebral artery over 7 years.
-
31
Intravascular Lithotripsy. [Review]
-
32
Letter by Khalid et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
-
33
Seeing is believing: Imaging guided treatment of calcified lesions.
-
34
Comment on "Modern-Day Nationwide Utilization of Intravascular Ultrasound and Its Impact on the Outcomes of Percutaneous Coronary Intervention With Coronary Atherectomy in the United States".
-
35
Entrapment of the Impella heart pump in the mitral subvalvular apparatus.
-
36
Reply to the letter to the editor "Impella device use in high-risk PCI".
-
37
Expanding the Treatment of Calcified Lesions.
-
38
Concertina effect: Incorporating intravascular imaging to aid in diagnosis.
-
39
Kissing Intravascular Lithotripsy Facilitated Endovascular Repair of a Complex Saccular Abdominal Aortic Aneurysm With Narrowed Distal Aorta: A First-in-Human Report.
-
40
Return of the Left Internal Mammary Artery.
-
41
The STRIATE-G Technique for COVID-19 ST-Segment Elevation Myocardial Infarction.
-
42
Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: A retrospective analysis of the MAUDE database.
-
43
Right Heart Catheterization-Related Complications: A Review of the Literature and Best Practices. [Review]
-
44
Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel Meeting on Device-Based Therapies for hypertension.
-
45
COVID-19 (SARS-Cov-2) and the heart - An ominous association.
-
46
Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: Insights from the Food and Drug Administration 2019 Circulatory System Devices Panel Meeting on late mortality. [Review]
-
47
Intravascular Ultrasound Assessment of the Impact of Intravascular Lithotripsy.
-
48
Resolution of Massive Intracoronary Thrombus During Percutaneous Coronary Intervention Utilizing Intensive Pharmacological and Aspiration Strategies.
-
49
Review of ACC 2020 late-breaking trials in interventional cardiology. [Review]
-
50
Should Non-ST-Elevation Myocardial Infarction be Treated like ST-Elevation Myocardial Infarction With Shorter Door-to-Balloon Time?.
-
51
Guidelines for balancing priorities in structural heart disease during the COVID-19 pandemic. [Review]
-
52
Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database.
-
53
Intravascular Lithotripsy Facilitated Percutaneous Endovascular Intervention of the Aortic Arch: A Single-Center Experience.
-
54
Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation.
-
55
Right transradial coronary angiography in the setting of tortuous brachiocephalic/thoracic aorta ("elephant head"): Impact on fluoroscopy time and contrast use.
-
56
Adverse Events and Modes of Failure Related to Impella RP: Insights from the Manufacturer and User Facility Device Experience (MAUDE) Database.
-
57
Adverse events with orbital atherectomy: an analytic review of the MAUDE database. [Review]
-
58
Adverse Events Associated with the Use of Guide Extension Catheters during Percutaneous Coronary Intervention: Reports from the Manufacturer and User Facility Device Experience (MAUDE) database.
-
59
Racial Disparities in Clinical Characteristics and Outcomes of Women Undergoing Percutaneous Coronary Intervention.
-
60
Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).
-
61
Unprotected Left Main Percutaneous Coronary Intervention With or Without Hemodynamic Support.
-
62
Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support.
-
63
Ischemic Versus Bleeding Outcomes After Percutaneous Coronary Interventions in Patients With High Bleeding Risk.
-
64
High-Risk Percutaneous Coronary Intervention of Native Coronary Arteries Without Mechanical Circulatory Support in Acute Coronary Syndrome Without Cardiogenic Shock.
-
65
Impact of Intravascular Ultrasound on Outcomes Following PErcutaneous Coronary InterventioN in Complex Lesions (iOPEN Complex).
-
66
Techniques to Optimize the Use of Optical Coherence Tomography: Insights from the Manufacturer and User Facility Device Experience (MAUDE) Database.
-
67
Real-World Experience of the Sentinel Cerebral Protection Device: Insights From the FDA Manufacturer and User Facility Device Experience (MAUDE) Database.
-
68
Real-World Experience of the MANTA Closure Device: Insights From the FDA Manufacturer and User Facility Device Experience (MAUDE) Database.
-
69
Trends in Death Rate 2009 to 2018 Following Percutaneous Coronary Intervention Stratified by Acuteness of Presentation.
-
70
Procedural Outcomes of Patients Undergoing Percutaneous Coronary Intervention for De Novo Lesions in the Ostial and Proximal Left Circumflex Coronary Artery.
-
71
Real-world experience of suture-based closure devices: Insights from the FDA Manufacturer and User Facility Device Experience.
-
72
One-Year Outcomes After Treatment of Ostial In-Stent Restenosis in Left Circumflex Versus Left Anterior Descending or Right Coronary Artery.
-
73
Adverse Events and Modes of Failure Related to Rotational Atherectomy System: The Utility of the MAUDE Database.